Kahn, Rene S.
- Brigham and Women's Hospital · Psychiatry (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #436
- Top 5% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#436
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kahn, Rene S. as a PI. Multi-PI records show the full award amount for context.
- 5U24MH124629-04U24Contact PIPsychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination CenterBrigham and Women's Hospital · Psychiatry (topic-inferred)$4.7Maward amount
- 3U24MH124629-04S1U24Contact PIPsychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination CenterBrigham and Women's Hospital · Psychiatry (topic-inferred)$2.4Maward amount
Award organization
Organizations that administered FY2023 awards listing Kahn, Rene S. as a PI.
FY2023 award administered by Brigham and Women's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardBrigham and Women's Hospital
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #781
- 2021Entered Top 25% NationallyRanked #781
- 2021Entered Top 10% NationallyRanked #781
- 2021Entered Top 5% NationallyRanked #781
- 2022$5M Cumulative Funding
- 2023$10M Cumulative Funding